Insider Selling: Liquidia (NASDAQ:LQDA) CEO Sells $1,528,250.00 in Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $61.13, for a total value of $1,528,250.00. Following the completion of the transaction, the chief executive officer directly owned 1,098,095 shares in the company, valued at $67,126,547.35. The trade was a 2.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Wednesday, May 27th, Roger Jeffs sold 6,428 shares of Liquidia stock. The stock was sold at an average price of $62.18, for a total value of $399,693.04.
• On Tuesday, May 26th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $60.38, for a total value of $1,509,500.00.
• On Tuesday, May 19th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $58.65, for a total value of $1,466,250.00.
• On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $57.04, for a total value of $1,426,000.00.
• On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $56.29, for a total value of $1,407,250.00.
• On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $41.50, for a total value of $1,037,500.00.
• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total value of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.10, for a total value of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The stock was sold at an average price of $40.60, for a total value of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total value of $1,003,500.00.

Liquidia Stock Performance

Shares of NASDAQ:LQDA opened at $62.03 on Friday. The company has a market capitalization of $5.52 billion, a P/E ratio of 443.10 and a beta of 0.41. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $63.46. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The business’s 50 day simple moving average is $44.03 and its 200 day simple moving average is $38.31.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. The business had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, research analysts anticipate that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. bought a new position in Liquidia during the 4th quarter worth $25,000. Covestor Ltd raised its position in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares in the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in shares of Liquidia in the 3rd quarter worth about $30,000. FNY Investment Advisers LLC bought a new stake in Liquidia in the 3rd quarter valued at about $34,000. Finally, NewEdge Advisors LLC bought a new stake in Liquidia in the 2nd quarter valued at about $25,000. 64.54% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on LQDA. HC Wainwright upped their target price on Liquidia from $55.00 to $67.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Wall Street Zen upgraded Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 16th. Oppenheimer upped their target price on Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research note on Thursday, March 12th. Jefferies Financial Group restated a “buy” rating and set a $60.00 target price on shares of Liquidia in a research note on Monday, May 11th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Three equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $50.88.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).